US targets Novo Nordisk's Ozempic and Wegovy for Medicare price talks

What are the limits in the fight against obesity? Ozempic owner disappoints the market

Sustaining long-term results is often the most difficult goal for those trying to lose weight. And the same challenge is faced by Novo Nordisk, the Danish laboratory that, back in 2018, introduced Ozempic: the injectable drug that revolutionized the fight against obesity. Seven years later — with a market capitalization of $382 billion, making it the largest firm in Europe — this pharmaceutical company is now struggling to stay in shape. Even th…

Medicare Targets 15 New Drugs for Price Negotiations

Popular diabetes (and weight loss) drugs like Ozempic and Wegovy have been added to Medicare's list of medications that will be negotiated directly between the government and drug manufacturers, the Biden administration said Friday. The price negotiations for the additional 15 drugs selected will be handled by the incoming Trump...

Hailing Ozempic Price Negotiation Plan, Sanders Asks: 'Will Trump Back Down' to Big Pharma?

"We will soon find out," said Sen. Bernie Sanders.

President Biden Had A Very Hard Time Saying The Word 'Ozempic'

President-elect Donald Trump's second inauguration comes on Monday, and for President Joe Biden it probably couldn't come a moment too soon, because the man can't help but stumble his way through speeches, even when he's taking a victory lap.Biden is at the point in his presidency where he's basically just going around trying to convince everybody that his presidency wasn't as terrible as we all know it was.One of the places on this whistle-stop…

Ozempic and Wegovy among drugs on Medicare list getting price cuts

Other drugs up for 2027 price decreases include a host of cancer drugs.

Ozempic among drugs targeted in upcoming Medicare price negotiations

Investors fret Novo Nordisk’s blockbuster treatments and other medicines could incur price cuts